Peter Hilgard
Impact in
-
- Research on Leishmaniasis Studies
- Hematology top 10%
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Chemical Synthesis and Analysis 2
- Co-authors
- R. Voegeli (7 shared papers)Jurij Stekar (7 shared papers)Ashish Goyal (1 shared paper)Shyam Sundar (1 shared paper)Andreas Voß (1 shared paper)M K Makharia (1 shared paper)F. Rosenkaimer (1 shared paper)Henry W. Murray (1 shared paper)
- Journals
- Investigational New Drugs (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)Cancer Treatment Reviews (3 papers)European Journal of Biochemistry (2 papers)Thrombosis Research (2 papers)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Peter Hilgard
32 papers receiving 703 citations
Peers
Comparison fields: 5 of 88
- Public Health, Environmental and Occupational Health 227
- Hematology 78
- Parasitology 44
- Oncology 125
- Cancer Research 67
Countries citing papers authored by Peter Hilgard
This map shows the geographic impact of Peter Hilgard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hilgard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hilgard more than expected).
Fields of papers citing papers by Peter Hilgard
This network shows the impact of papers produced by Peter Hilgard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hilgard. The network helps show where Peter Hilgard may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hilgard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 192 | |
| 2 | 1988 | 92 | |
| 3 | 1990 | 50 | |
| 4 | 1972 | 44 | |
| 5 | 1998 | 40 | |
| 6 | 1985 | 31 | |
| 7 | 1995 | 29 | |
| 8 | 1993 | 27 | |
| 9 | 1982 | 26 | |
| 10 | 1989 | 24 | |
| 11 | 1988 | 20 | |
| 12 | 1997 | 19 | |
| 13 | 1995 | 18 | |
| 14 | 1992 | 16 | |
| 15 | 1973 | 16 | |
| 16 | 1984 | 14 | |
| 17 | 1990 | 12 | |
| 18 | 1995 | 12 | |
| 19 | 1984 | 12 | |
| 20 | 1990 | 9 |
About Peter Hilgard
Peter Hilgard is a scholar working on Molecular Biology, Hematology, Organic Chemistry, Immunology and Oncology, having authored 32 papers that have together received 747 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Chemotherapy-induced organ toxicity mitigation (3 papers), Virus-based gene therapy research (2 papers), Hypothalamic control of reproductive hormones (2 papers), Chemical Synthesis and Analysis (2 papers), Viral Infections and Immunology Research (2 papers), Immune Cell Function and Interaction (2 papers) and Synthetic Organic Chemistry Methods (2 papers). The work is most often cited by research in Public Health, Environmental and Occupational Health (227 citations), Hematology (78 citations), Parasitology (44 citations), Oncology (125 citations) and Cancer Research (67 citations). Peter Hilgard has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include R. Voegeli, Jurij Stekar, Ashish Goyal, Shyam Sundar, Andreas Voß, M K Makharia, F. Rosenkaimer, Henry W. Murray, Clemens Unger and Jürgen Engel. Their work appears in journals such as Investigational New Drugs, Cancer Chemotherapy and Pharmacology, Cancer Treatment Reviews, European Journal of Biochemistry and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.